Menu Search
Equities

Kainos Laboratories Inc

4556:TYO

Kainos Laboratories Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)1,195.00
  • Today's Change-17.00 / -1.40%
  • Shares traded1.20k
  • 1 Year change+11.58%
  • Beta0.8009
Data delayed at least 20 minutes, as of Nov 15 2024 05:15 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Kainos Laboratories Inc had relatively flat revenues (4.92bn to 5.06bn), though the company grew net income 12.28% from 568.18m to 637.97m. A reduction in the selling, general and administrative costs as a percentage of sales from 29.74% to 29.00% was a component in the net income growth despite flat revenues.
Gross margin50.18%
Net profit margin11.76%
Operating margin15.43%
Return on assets7.43%
Return on equity9.92%
Return on investment9.21%
More ▼

Cash flow in JPYView more

In 2024, Kainos Laboratories Inc increased its cash reserves by 5.75%, or 154.04m. The company earned 430.58m from its operations for a Cash Flow Margin of 8.52%. In addition the company used 72.83m on investing activities and also paid 203.73m in financing cash flows.
Cash flow per share172.77
Price/Cash flow per share7.49
Book value per share1,533.73
Tangible book value per share1,528.77
More ▼

Balance sheet in JPYView more

Kainos Laboratories Inc appears to have a strong balance sheet and has grown its cash reserves consistently over the last four years to total 3.17bn. In fact, 0.58% of the value of Kainos Laboratories Inc shares can be attributed to this cash.
Current ratio3.66
Quick ratio3.11
Total debt/total equity0.0851
Total debt/total capital0.0784
More ▼

Growth rates in JPY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 28.00% and 11.85%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is above the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)2.16%
Div growth rate (5 year)16.36%
Payout ratio (TTM)23.12%
EPS growth(5 years)9.09
EPS (TTM) vs
TTM 1 year ago		5.40
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.